3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Squamous Cell Carcinoma of Head and Neck
4
Head and Neck Neoplasms
2
Virus Diseases
1
Tumor Virus Infections
1
Recurrence
1
Pharyngeal Diseases
1
Papillomavirus Infections
1
Otorhinolaryngologic Neoplasms
1
Otorhinolaryngologic Diseases
1
Oropharyngeal Neoplasms
1
Neoplasms, Squamous Cell
1
Neoplasms, Glandular and Epithelial
1
Neoplasms by Site
1
Neoplasms by Histologic Type
1
Locally Advanced Head and Neck HPV Negative Squamous Cell Cancers
1
Laryngeal Diseases
1
Hypoxia
1
DNA Virus Infections
1
Carcinoma, Squamous Cell
1
Carcinoma
1
Interventions
Radiotherapy, Intensity-Modulated
7
Cisplatin
7
Carboplatin
5
Surveys and Questionnaires
3
Paclitaxel
3
Taxes
2
Radiation
2
Docetaxel
2
Cetuximab
2
Albumin-Bound Paclitaxel
2
utomilumab
1
toripalimab
1
infigratinib
1
fludarabine phosphate
1
fludarabine
1
durvalumab
1
aldesleukin
1
Specimen Handling
1
Radiotherapy
1
Platinum
1
Nimorazole
1
Mass Screening
1
Liquid Biopsy
1
Immunoglobulin G
1
Hydroxyurea
1
Gene Expression Profiling
1
Focus Groups
1
Fluorouracil
1
Drug Therapy
1
Disulfides
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Papillomavirus Infections
×
Nimorazole
×
Head & Neck
×
Clear all
NCT04124198
2025-12-31
QoLATI
Rigshospitalet, Denmark
Phase NA
Active not recruiting
138 enrolled